Stock Scorecard

Stock Summary for Longboard Pharmaceuticals Inc (LBPH) - $59.77 as of 11/20/2024 8:22:18 PM EST

Total Score

9 out of 30

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for LBPH

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for LBPH

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for LBPH

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for LBPH

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for LBPH (25 out of 90)

Stock Price Rating (Max of 10) 9
Historical Stock Price Rating (Max of 10) 1
Stock Price Trend (Max of 10) 0
Book Value (Max of 10) 4
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 2
Analyst Strong Buy Ratings (Max of 5) 3
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 0
Trading Volume (Max of 10) 6
Price to Earnings (Max of 10) 0

Latest News for for LBPH

SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Continues to Investigate the Mergers of MARX, BRKH, MNTX and LPBH 11/20/2024 11:06:00 PM
Zacks Industry Outlook Highlights Exelixis, Blueprint Medicines, CRISPR, Amicus and Verona Pharma 10/25/2024 8:59:00 AM
5 Biotech Stocks Likely to Outperform as Industry Prospects Look Bright 10/24/2024 1:06:00 PM
Deal Dispatch: Altus Power, Motorsport Games Explore Options, True Value Goes Bankrupt, M&A Activity Lags - Apollo Global Management ( NYSE:APO ) , Altus Power ( NYSE:AMPS ) 10/21/2024 6:46:00 PM
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LBPH and ARC on Behalf of Shareholders - ARC Document Solutions ( NYSE:ARC ) , Longboard Pharmaceuticals ( NASDAQ:LBPH ) 10/17/2024 9:45:00 PM
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LBPH and OB on Behalf of Shareholders - Outbrain ( NASDAQ:OB ) , Longboard Pharmaceuticals ( NASDAQ:LBPH ) 10/15/2024 10:47:00 PM
Longboard Set to be Acquired by Lundbeck for $2.6B, Stock Soars 52% 10/15/2024 2:13:00 PM
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Longboard Pharmaceuticals ( Nasdaq - LBPH ) , Village Bank and Trust Financial Corp. ( Nasdaq - VBFC ) , Smartsheet Inc. ( NYSE - SMAR ) , Northway Financial, Inc. ( OTCQB - NWYF ) 10/14/2024 8:18:00 PM
Dow Surges Over 200 Points; Longboard Pharmaceuticals Shares Jump - Longboard Pharmaceuticals ( NASDAQ:LBPH ) 10/14/2024 7:06:00 PM
NVIDIA, Trump Media & Technology, Bausch + Lomb, Sirius XM And Other Big Stocks Moving Higher On Monday - NVIDIA ( NASDAQ:NVDA ) 10/14/2024 5:47:00 PM

Financial Details for LBPH

Company Overview
Ticker LBPH
Company Name Longboard Pharmaceuticals Inc
Country USA
Description Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of drugs for neurological diseases. The company is headquartered in San Diego, California.
Sector Name LIFE SCIENCES
Industry Name PHARMACEUTICAL PREPARATIONS
Most Recent Quarter 9/30/2024
Next Earnings Date N/A

Stock Price History
Last Day Price 59.77
Price 4 Years Ago 0.00
Last Day Price Updated 11/20/2024 8:22:18 PM EST
Last Day Volume 703,657
Average Daily Volume 2,777,845
52-Week High 59.95
52-Week Low 3.60
Last Price to 52 Week Low 1,560.28%

Valuation Measures
Trailing PE N/A
Industry PE 22.60
Sector PE 40.32
5-Year Average PE -6.69
Free Cash Flow Ratio 7.14
Industry Free Cash Flow Ratio 12.03
Sector Free Cash Flow Ratio 27.97
Current Ratio Most Recent Quarter 15.97
Total Cash Per Share 8.37
Book Value Per Share Most Recent Quarter 7.05
Price to Book Ratio 8.47
Industry Price to Book Ratio 5.31
Sector Price to Book Ratio 20.88
Price to Sales Ratio Twelve Trailing Months 0.00
Industry Price to Sales Ratio Twelve Trailing Months 11.82
Sector Price to Sales Ratio Twelve Trailing Months 7.11
Analyst Buy Ratings 1
Analyst Strong Buy Ratings 1

Share Statistics
Total Shares Outstanding 34,436,200
Market Capitalization 2,058,251,674
Institutional Ownership N/A

Dividends
Ex-Dividend Date N/A
Last Dividend Amount 0.00
Current Dividend Amount 0.00
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement
Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth -23.84%
Reported EPS 12 Trailing Months -2.25
Reported EPS Past Year -1.61
Reported EPS Prior Year -2.38
Net Income Twelve Trailing Months -76,344,000
Net Income Past Year -54,422,000
Net Income Prior Year -43,945,000
Quarterly Revenue Growth YOY 0.00%
5-Year Revenue Growth 0.00%
Operating Margin Twelve Trailing Months 0.00

Balance Sheet
Total Cash Most Recent Quarter 288,400,000
Total Cash Past Year 48,500,000
Total Cash Prior Year 67,600,000
Net Cash Position Most Recent Quarter 288,400,000
Net Cash Position Past Year 48,500,000
Long Term Debt Past Year 0
Long Term Debt Prior Year 0
Total Debt Most Recent Quarter 0
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 1.00
Total Stockholder Equity Past Year 40,923,000
Total Stockholder Equity Prior Year 61,470,000
Total Stockholder Equity Most Recent Quarter 275,186,000

Free Cash Flow
Free Cash Flow Twelve Trailing Months -65,931,000
Free Cash Flow Per Share Twelve Trailing Months -1.91
Free Cash Flow Past Year 0
Free Cash Flow Prior Year -38,063,000

Options
Put/Call Ratio 0.04
Has Options Options Chain
Liquidity Rating

Technical Analysis
Yahoo Finance Chart Yahoo Finance Chart
MACD 3.68
MACD Signal 4.59
20-Day Bollinger Lower Band 20.04
20-Day Bollinger Middle Band 41.34
20-Day Bollinger Upper Band 62.64
Beta 1.09
RSI 77.49
50-Day SMA 27.30
150-Day SMA 12.51
200-Day SMA 0.00

System
Modified 11/19/2024 5:11:19 AM EST